CO6220901A2 - Preparacion farmaceutica acuosa - Google Patents
Preparacion farmaceutica acuosaInfo
- Publication number
- CO6220901A2 CO6220901A2 CO09105019A CO09105019A CO6220901A2 CO 6220901 A2 CO6220901 A2 CO 6220901A2 CO 09105019 A CO09105019 A CO 09105019A CO 09105019 A CO09105019 A CO 09105019A CO 6220901 A2 CO6220901 A2 CO 6220901A2
- Authority
- CO
- Colombia
- Prior art keywords
- pharmaceutical preparation
- aqueous pharmaceutical
- preparation according
- polyoxyethylene
- hydroxyl group
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4741—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having oxygen as a ring hetero atom, e.g. tubocuraran derivatives, noscapine, bicuculline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Immunology (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Urology & Nephrology (AREA)
- Ophthalmology & Optometry (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Transplantation (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1.- Preparación farmacéutica acuosa que contiene 1- (2-dimetilamino-etil)-3-((2R,4aS,5R,10bS)-5-fenil-9- trifluorometil-3, 4, 4a, 5, 6, 10b-hexahidro-2H-pirano [3,2-c]quinolin-2-ilmetil)-urea como principio activo, al menos un tensioactivo no iónico y al menos un solvente orgánico que contiene por lo menos un grupo hidroxilo. 2.- Preparación farmacéutica acuosa de acuerdo con la reivindicación 1, caracterizada porque el o los tensioactivos no iónicos presentan un valor HLB > 8.3.- Preparación farmacéutica acuosa de acuerdo con la reivindicación 2, caracterizada porque como tensioactivos no iónicos están contenidos éster de ácido graso de polioxietilen-sorbitano, copolímeros de polioxietileno-polioxipropileno, éster de ácido graso de polietilenglicol y/o éster de ácido hidroxiácido de polietilenglicol. 4.- Preparación farmacéutica acuosa de acuerdo con la reivindicación 3, caracterizada porque como tensioactivos no iónicos están contenidos ricinoleato de glicerina-polietilenglicol, monooleato de polioxietilen(20)-sorbitano, monoestearato de polioxietilen(20)-sorbitano, copolímero de bloque de polioxietileno-polioxipropileno y/o un hidroxiestearato de polietilenglicol (15). 5.- Preparación farmacéutica acuosa de acuerdo con una o varias de las reivindicaciones 1 al 4, caracterizada porque como solventes orgánicos que contienen al menos un grupo hidroxilo están contenidos alcoholes mono- o polivalentes y/o polietilenglicoles. 6.- Preparación farmacéutica acuosa de acuerdo con la reivindicación 5, caracterizada porque como solventes orgánicos que contienen al menos un grupo hidroxilo están contenidos etanol, propilenglicol, glicerina, glucofurol y/o polietilenglicoles. 7.- Preparación farmacéutica acuosa de acuerdo con la reivindicación 6, caracterizada porque como solvente orgánico está contenido etanol. 8.- Preparación farmacéutica acuosa de acuerdo con una o varias de las reivindicaciones 1 al 7, caracterizada porque contiene 0,1 al 20% en peso de tensioactivos no iónicos y 0,05 al 20% en peso de al menos un solvente orgánico que contiene por lo menos un grupo hidroxilo.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102007021862A DE102007021862A1 (de) | 2007-05-10 | 2007-05-10 | Wässrige pharmazeutische Zubereitung |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6220901A2 true CO6220901A2 (es) | 2010-11-19 |
Family
ID=39537491
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO09105019A CO6220901A2 (es) | 2007-05-10 | 2009-09-25 | Preparacion farmaceutica acuosa |
Country Status (20)
Country | Link |
---|---|
US (1) | US20100210681A1 (es) |
EP (1) | EP2142169B1 (es) |
JP (1) | JP2010526783A (es) |
KR (1) | KR20100029758A (es) |
CN (1) | CN101677941A (es) |
AR (1) | AR066504A1 (es) |
AT (1) | ATE530164T1 (es) |
AU (1) | AU2008250717A1 (es) |
BR (1) | BRPI0811431A2 (es) |
CA (1) | CA2686765A1 (es) |
CL (1) | CL2008001384A1 (es) |
CO (1) | CO6220901A2 (es) |
DE (1) | DE102007021862A1 (es) |
EA (1) | EA200901498A1 (es) |
EC (1) | ECSP099788A (es) |
IL (1) | IL201912A0 (es) |
MX (1) | MX2009012035A (es) |
PE (1) | PE20090246A1 (es) |
TW (1) | TW200911252A (es) |
WO (1) | WO2008138459A2 (es) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2948568B1 (fr) * | 2009-07-30 | 2012-08-24 | Sanofi Aventis | Formulation pharmaceutique |
US20130029919A1 (en) * | 2011-07-26 | 2013-01-31 | Allergan, Inc. | Two part formulation system for opthalmic delivery |
KR102126727B1 (ko) | 2018-03-29 | 2020-07-07 | 이혜영 | 자동차 표면 광택방법 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE507220T1 (de) * | 2003-12-20 | 2011-05-15 | Merck Patent Gmbh | Tetrahydropyranochinolinderivate |
US7361683B2 (en) * | 2004-11-24 | 2008-04-22 | Yung Shin Pharm. Ind., Co., Ltd | Paclitaxel aqueous injection solution and methods for preparing the same |
NZ574236A (en) * | 2006-06-19 | 2010-11-26 | Merck Patent Gmbh | Processes for preparing pyranoquinolines and crystal forms thereof |
-
2007
- 2007-05-10 DE DE102007021862A patent/DE102007021862A1/de not_active Withdrawn
-
2008
- 2008-04-24 WO PCT/EP2008/003291 patent/WO2008138459A2/de active Application Filing
- 2008-04-24 MX MX2009012035A patent/MX2009012035A/es active IP Right Grant
- 2008-04-24 BR BRPI0811431-5A patent/BRPI0811431A2/pt not_active IP Right Cessation
- 2008-04-24 JP JP2010506818A patent/JP2010526783A/ja not_active Abandoned
- 2008-04-24 AU AU2008250717A patent/AU2008250717A1/en not_active Abandoned
- 2008-04-24 US US12/599,427 patent/US20100210681A1/en not_active Abandoned
- 2008-04-24 EA EA200901498A patent/EA200901498A1/ru unknown
- 2008-04-24 KR KR1020097025713A patent/KR20100029758A/ko not_active Application Discontinuation
- 2008-04-24 AT AT08749090T patent/ATE530164T1/de active
- 2008-04-24 CA CA002686765A patent/CA2686765A1/en not_active Abandoned
- 2008-04-24 EP EP08749090A patent/EP2142169B1/de not_active Not-in-force
- 2008-04-24 CN CN200880015535A patent/CN101677941A/zh active Pending
- 2008-05-08 PE PE2008000805A patent/PE20090246A1/es not_active Application Discontinuation
- 2008-05-09 CL CL2008001384A patent/CL2008001384A1/es unknown
- 2008-05-09 AR ARP080101966A patent/AR066504A1/es unknown
- 2008-05-09 TW TW097117319A patent/TW200911252A/zh unknown
-
2009
- 2009-09-25 CO CO09105019A patent/CO6220901A2/es not_active Application Discontinuation
- 2009-11-03 IL IL201912A patent/IL201912A0/en unknown
- 2009-12-08 EC EC2009009788A patent/ECSP099788A/es unknown
Also Published As
Publication number | Publication date |
---|---|
AR066504A1 (es) | 2009-08-26 |
CL2008001384A1 (es) | 2009-09-25 |
IL201912A0 (en) | 2010-06-16 |
DE102007021862A1 (de) | 2008-11-13 |
ECSP099788A (es) | 2010-01-29 |
AU2008250717A1 (en) | 2008-11-20 |
PE20090246A1 (es) | 2009-03-19 |
ATE530164T1 (de) | 2011-11-15 |
US20100210681A1 (en) | 2010-08-19 |
WO2008138459A2 (de) | 2008-11-20 |
KR20100029758A (ko) | 2010-03-17 |
JP2010526783A (ja) | 2010-08-05 |
EP2142169A2 (de) | 2010-01-13 |
BRPI0811431A2 (pt) | 2015-06-16 |
EP2142169B1 (de) | 2011-10-26 |
CA2686765A1 (en) | 2008-11-20 |
TW200911252A (en) | 2009-03-16 |
WO2008138459A3 (de) | 2009-06-04 |
MX2009012035A (es) | 2009-11-18 |
EA200901498A1 (ru) | 2010-04-30 |
CN101677941A (zh) | 2010-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2011126883A (ru) | Биологически активные композиции для полоскания полости рта с эфирными маслами без спирта | |
CN101909450B (zh) | 用于抗击寄生物的浇泼配制剂的溶剂系统 | |
NZ596657A (en) | Self micro-emulsifying oral pharmaceutical composition of hydrophilic drug and preparation method thereof | |
GB2544468A (en) | Liquid formulation | |
PE20191714A1 (es) | Nanoparticula polimerica de finasterida y minoxidil, proceso de preparacion, suspension acuosa conteniendo la misma, composicion farmaceutica, y su uso | |
CL2012000888A1 (es) | Mezclas fungicidas que comprende un compuesto derivado de 1,5 dioxonan-2,6-diona y un segundo compuesto activo fungincida seleccionado de conazol, tales como epoxiconazol, protioconazol y procloraz; y composicion fungincida que las contiene. | |
AR075284A1 (es) | Formulaciones fitosanitarias liquidas acuosas | |
EA022068B1 (ru) | Паразитицидные композиции, содержащие несколько активных агентов, способы и их применения | |
PE20020261A1 (es) | Sistemas auto-emulsionantes de administracion de medicinas para drogas lipofilicas extremadamente insolubles en agua | |
PE20120322A1 (es) | Composicion farmaceutica que comprende faldaprevir o una sal del mismo en un vehiculo auto-emulsionante | |
AR092402A1 (es) | Nanoparticula polimerica de finasterida, suspension acuosa conteniendo a la misma, composicion para tratamiento de alopecia, proceso de preparacion de dicha composicion, y su uso | |
EP1610613A2 (en) | Topical anthelmintic veterinary formulations | |
ES2554245T3 (es) | Formulaciones parasiticidas inyectables de levamisol y lactonas macrocíclicas | |
ECSP11010833A (es) | Procedimiento para controlar la degradación de un ingrediente activo químico agrícola | |
CO6220901A2 (es) | Preparacion farmaceutica acuosa | |
AR090606A1 (es) | Composicion pesticida | |
AR094874A1 (es) | Formulaciones para el tratamiento de semillas | |
ECSP21039539A (es) | Mezclas y composiciones que comprenden 5-fluoro-4-imino-3-metil-1-tosil-3,4-dihidropirimidin-2-ona, y métodos de uso de los mismos | |
ES2846820T3 (es) | Composición de lactonas macrocíclicas, levamisol, un aminoazúcar y un agente antiparasitario adicional | |
AU2017308788B2 (en) | Moxidectin topical liquid formulations | |
AR084235A1 (es) | Composiciones farmaceuticas que comprenden alisporivir | |
ES2531241T3 (es) | Composición farmacéutica líquida estable a base de trazodona | |
AR078165A1 (es) | Adhesivo de hidrogel para protesis dentales, su preparacion | |
RU2011112990A (ru) | Бензимидазольные антигельминтные композиции | |
RU2011124647A (ru) | Мазь с экстрактом личинок большой восковой моли и экстрактом прополиса для профилактики и комплексного лечения вирусной инфекции |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Application refused |